Form 8-K - Current report:
SEC Accession No. 0001104659-25-029124
Filing Date
2025-03-28
Accepted
2025-03-28 11:12:28
Documents
18
Period of Report
2025-03-28
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2510789d1_8k.htm   iXBRL 8-K 27389
2 EXHIBIT 99.1 tm2510789d1_ex99-1.htm EX-99.1 11699
3 EXHIBIT 99.2 tm2510789d1_ex99-2.htm EX-99.2 7202
7 GRAPHIC tm2510789d1_ex99-2img001.jpg GRAPHIC 45869
8 GRAPHIC tm2510789d1_ex99-2img002.jpg GRAPHIC 183943
9 GRAPHIC tm2510789d1_ex99-2img003.jpg GRAPHIC 159977
  Complete submission text file 0001104659-25-029124.txt   755040

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA ptct-20250328.xsd EX-101.SCH 3009
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE ptct-20250328_lab.xml EX-101.LAB 34240
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ptct-20250328_pre.xml EX-101.PRE 22355
20 EXTRACTED XBRL INSTANCE DOCUMENT tm2510789d1_8k_htm.xml XML 3574
Mailing Address 500 WARREN CORPORATE CENTER DRIVE WARREN NJ 07059
Business Address 500 WARREN CORPORATE CENTER DRIVE WARREN NJ 07059 9082227000
PTC THERAPEUTICS, INC. (Filer) CIK: 0001070081 (see all company filings)

EIN.: 043416587 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35969 | Film No.: 25782173
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)